Inhibition of the CXCR4/PLC axis significantly overcame Dex resistance in B-ALL cell lines (both in vitro and in vivo), as well as in cells from Dex-resistant ALL patients [19]. The gene discussed is HSPG2; the disease is acute lymphoblastic leukemia.